- ICH GCP
- Register voor klinische proeven in de VS.
- Klinische proef NCT02086305
Transitional Palliative Care in End-stage Heart Failure
Effects of a Transitional Palliative Care Model on Patients With End-stage Heart Failure
Palliative care for end-stage organ failure patients has been included as one of the key programs to be implemented in 2011-2012 in the Hospital Authority, Hong Kong. Among all the disease groups, end-stage heart failure patients have the highest mortality rate. Patients at the end stage of heart failure have health concerns shared by other end-stage patients including cancer patients. Many guidelines, local and world-wide, have advocated a palliative approach of care for those heart failure patients who are at end stage. Studies have shown that end-stage heart failure patients tend to have frequent emergency room visits and repeated hospital admissions. Also, these patients suffer from a number of health problems that adversely affect their Quality Of Life.
There is scarcity of experimental studies informing practitioners which models work best for palliative patients in Hong Kong. There were randomized controlled trials conducted outside Hong Kong which suggest multidisciplinary approach of palliative care is possible to reduce readmissions but evidence is not present for other outcomes such as symptom control and carer burden.
In an attempt to fill knowledge gap and inform practice using evidence, this study is launched to compare the effects of a customary hospital-based palliative heart failure care and an interventional Home-based Palliative heart failure Program.
Hypothesis
- there is no difference in health care utilization for end-stage heart failure patients between the customary hospital-based group and the Home based palliative heart failure program group
- there is no difference in evaluated health outcomes (functional status, symptom intensity, and satisfaction with care) between the customary hospital-based group and the Home based palliative heart failure program group
- there is no difference in perceived health outcomes (quality of life, caregiver burden) between the customary hospital-based group and the Home based palliative heart failure program group
- there is no difference in cost effectiveness between the customary hospital-based group and the Home based palliative heart failure program group
- there is no difference In patients' lived experiences between the customary hospital-based group and the Home based palliative heart failure program group
Studie Overzicht
Toestand
Conditie
Interventie / Behandeling
Gedetailleerde beschrijving
Studietype
Inschrijving (Werkelijk)
Fase
- Niet toepasbaar
Contacten en locaties
Studie Locaties
-
-
-
Hong Kong, Hongkong
- Grantham Hospital
-
Hong Kong, Hongkong
- Haven of Hope Hospital
-
Hong Kong, Hongkong
- United Christian Hospital
-
-
Deelname Criteria
Geschiktheidscriteria
Leeftijden die in aanmerking komen voor studie
- Kind
- Volwassen
- Oudere volwassene
Accepteert gezonde vrijwilligers
Geslachten die in aanmerking komen voor studie
Beschrijving
Inclusion Criteria:
- Ability to speak Cantonese
- Living within the hospital service area
- Ability to be contacted by phone
Identified as end-stage heart failure eligible for palliative care, guided by Prognostic Indicator Guidance, National Gold Standards Framework,to fulfill at least two of the indicators below:
(i) Congestive heart failure New York Heart Association stage III or IV (ii) Patient thought to be in the last year of life by the care team (iii) Repeated hospital admissions with symptoms of heart failure (3 hospital admissions within one year) (iv) Existence of physical or psychological symptoms despite optimal tolerated therapy
Exclusion Criteria:
- Discharged to nursing home or other institution
- Inability to communicate
- Diagnosed with severe psychiatric disorders such as schizophrenia, bipolar disorder
Studie plan
Hoe is de studie opgezet?
Ontwerpdetails
- Primair doel: Ondersteunende zorg
- Toewijzing: Gerandomiseerd
- Interventioneel model: Parallelle opdracht
- Masker: Enkel
Wapens en interventies
Deelnemersgroep / Arm |
Interventie / Behandeling |
---|---|
Experimenteel: Usual Care + Transitional Care Model
Transitional Care, Evidence-based symptom management, Protocol-driven home visit and telephone follow-up, Trained nurse case manager and volunteer partnership
|
Symptom assessment and management, care goal setting, post-discharge support
Usual care is the routine practice in the hospital
|
Actieve vergelijker: Usual Care
Usual care
|
Usual care is the routine practice in the hospital
|
Wat meet het onderzoek?
Primaire uitkomstmaten
Uitkomstmaat |
Maatregel Beschrijving |
Tijdsspanne |
---|---|---|
Healthcare utilization
Tijdsspanne: up to 12 months
|
The time from hospital discharge to hospital readmission using hospital clinical management system to retrieve data
|
up to 12 months
|
Secundaire uitkomstmaten
Uitkomstmaat |
Maatregel Beschrijving |
Tijdsspanne |
---|---|---|
Quality of Life
Tijdsspanne: baseline, 1 month, 3 months, 6 months, 12 month
|
Change from baseline in quality of life on the palliative specific McGill Quality of Life Questionnaire Hong Kong version (MQOL-HK) at 1 month; change from baseline in MQOL-HK at 3 months; change from baseline in MQOL-HK at 6 months; change from baseline in MQOL-HK at 12 months
|
baseline, 1 month, 3 months, 6 months, 12 month
|
Quality of Life
Tijdsspanne: Baseline, 1 month, 3 months, 6 months, 12 months
|
Change from baseline in quality of life on the heart failure specific Chronic Heart Failure Questionnaire-Chinese version (CHQ) at 1 month; change from baseline in CHQ score at 3 months; change from baseline in CHQ score at 6 months; change from baseline in CHQ score at 12 months
|
Baseline, 1 month, 3 months, 6 months, 12 months
|
Functional status
Tijdsspanne: Baseline, 1 month, 3 months, 6 months, 12 months
|
Change from baseline in functional status on the Palliative Performance Scale (PPS) at 1 month; change from baseline in PPS at 3 months; change from baseline in PPS at 6 months; change from baseline in PPS at 12 months
|
Baseline, 1 month, 3 months, 6 months, 12 months
|
Symptom intensity
Tijdsspanne: Baseline, 1 month, 3 month, 6 month, 12 month
|
Change from baseline in symptom intensity on the Edmonton Symptom Assessment System (ESAS) at 1 month; change from baseline in ESAS score at 3 month; change from baseline in ESAS score at 6 month; change from baseline in ESAS score at 12 month.
|
Baseline, 1 month, 3 month, 6 month, 12 month
|
Satisfaction with care
Tijdsspanne: 1 month, 3 months, 6 months, 12 months
|
Change from 1 month in satisfaction with care on the 15-item questionnaire developed by the principal investigator which validity confirmed by an expert panel and reported test-retest reliability of .87
(Sat-care) at 3 month; change from 1 month in Sat-care score at 6 months; change from 1 month in Sat-care score at 12 months
|
1 month, 3 months, 6 months, 12 months
|
Caregiver burden
Tijdsspanne: Baseline, 1 month, 3 months, 6 months, 12 months
|
Change from baseline in caregiver burden on the Zarit Caregiver Burden Scale (ZCBS) at 1 month; change from baseline in ZCBS score at 3 months; change from baseline in ZCBS score at 6 months; change from baseline in ZCBS score at 12 months
|
Baseline, 1 month, 3 months, 6 months, 12 months
|
Medewerkers en onderzoekers
Onderzoekers
- Hoofdonderzoeker: Frances KY Wong, The Hong Kong Polytechnic University
Publicaties en nuttige links
Algemene publicaties
- Wong FKY, So C, Ng AYM, Lam PT, Ng JSC, Ng NHY, Chau J, Sham MMK. Cost-effectiveness of a transitional home-based palliative care program for patients with end-stage heart failure. Palliat Med. 2018 Feb;32(2):476-484. doi: 10.1177/0269216317706450. Epub 2017 Apr 24.
- Ng AY, Wong FK, Lee PH. Effects of a transitional palliative care model on patients with end-stage heart failure: study protocol for a randomized controlled trial. Trials. 2016 Mar 31;17:173. doi: 10.1186/s13063-016-1303-7.
Studie record data
Bestudeer belangrijke data
Studie start
Primaire voltooiing (Werkelijk)
Studie voltooiing (Werkelijk)
Studieregistratiedata
Eerst ingediend
Eerst ingediend dat voldeed aan de QC-criteria
Eerst geplaatst (Schatting)
Updates van studierecords
Laatste update geplaatst (Werkelijk)
Laatste update ingediend die voldeed aan QC-criteria
Laatst geverifieerd
Meer informatie
Termen gerelateerd aan deze studie
Trefwoorden
Aanvullende relevante MeSH-voorwaarden
Andere studie-ID-nummers
- PolyU5492
Deze informatie is zonder wijzigingen rechtstreeks van de website clinicaltrials.gov gehaald. Als u verzoeken heeft om uw onderzoeksgegevens te wijzigen, te verwijderen of bij te werken, neem dan contact op met register@clinicaltrials.gov. Zodra er een wijziging wordt doorgevoerd op clinicaltrials.gov, wordt deze ook automatisch bijgewerkt op onze website .
Klinische onderzoeken op Hartfalen
-
University Hospital TuebingenVoltooidHeart Assist-apparaatDuitsland
-
University of ChicagoVoltooidHartfalen | Heart Assist-apparaat | HyponatremischVerenigde Staten
-
Region SkaneAanmelden op uitnodigingHartfalen New York Heart Association (NYHA) Klasse II | Hartfalen New York Heart Association (NYHA) Klasse IIIZweden
-
Carmel Medical CenterOnbekendPneumoperitoneum | Heart Output StoornisIsraël
-
Medical University of BialystokInstitute of Cardiology, Warsaw, Poland; Medical University of Lodz; Poznan University... en andere medewerkersNog niet aan het wervenHartfalen, systolisch | Hartfalen met verminderde ejectiefractie | Hartfalen New York Heart Association Klasse IV | Hartfalen New York Heart Association Klasse IIIPolen
-
Triple-Gene, LLCIntrexon Corporation; Precigen, IncVoltooidHart-en vaatziekten | Hartfalen | Heart-Assist-apparaatVerenigde Staten
-
University of WashingtonAmerican Heart AssociationVoltooidHartfalen, congestief | Mitochondriale verandering | Hartfalen New York Heart Association Klasse IVVerenigde Staten
-
Novartis PharmaceuticalsVoltooidPatiënten die de behandelingsperiode van 12 maanden van de kernstudie met succes hebben afgerond (de Novo Heart-ontvangers) die geïnteresseerd waren om behandeld te worden met EC-MPS
Klinische onderzoeken op Transitional Care Model
-
McMaster UniversityHamilton Health Sciences Corporation; Ontario Ministry of Health and Long Term... en andere medewerkersVoltooid
-
Johnson & Johnson Surgical Vision, Inc.Beëindigd
-
University of ParmaVoltooidMotorische activiteit | Hemiplegie Cerebrale PareseItalië
-
Johnson & Johnson Surgical Vision, Inc.Actief, niet wervend
-
University of PittsburghPatient-Centered Outcomes Research InstituteVoltooidGehoorverlies, leeftijdsgerelateerdVerenigde Staten
-
CORD, LLCBeëindigd
-
National University, SingaporeOnbekend
-
Johnson & Johnson Surgical Vision, Inc.Werving
-
MicroPort CRMVoltooidTachycardieSpanje, Verenigde Staten, Verenigd Koninkrijk, Frankrijk, Japan, Duitsland, Italië